168 related articles for article (PubMed ID: 31080611)
1. Do pathologists agree with each other on the histological assessment of pT1b oesophageal adenocarcinoma?
Gotink AW; Ten Kate FJ; Doukas M; Wijnhoven BP; Bruno MJ; Looijenga LH; Koch AD; Biermann K
United European Gastroenterol J; 2019 Mar; 7(2):261-269. PubMed ID: 31080611
[TBL] [Abstract][Full Text] [Related]
2. Measuring depth of invasion of submucosa - invasive adenocarcinoma in oesophageal endoscopic specimens: how good are we?
Karamchandani DM; Gonzalez RS; Westerhoff M; Westbrook LM; Panarelli NC; Al-Nuaimi M; King T; Arnold CA
Histopathology; 2022 Jan; 80(2):420-429. PubMed ID: 34519098
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low-risk tumours are not associated with lymph node metastases.
Benech N; O'Brien JM; Barret M; Jacques J; Rahmi G; Perrod G; Hervieu V; Jaouen A; Charissoux A; Guillaud O; Legros R; Walter T; Saurin JC; Rivory J; Prat F; Lépilliez V; Ponchon T; Pioche M
United European Gastroenterol J; 2021 Apr; 9(3):362-369. PubMed ID: 32903167
[TBL] [Abstract][Full Text] [Related]
4. Inter-Observer Variability in the Interpretation of Endoscopic Mucosal Resection Specimens of Esophageal Adenocarcinoma: Interpretation of ER specimens.
Worrell SG; Boys JA; Chandrasoma P; Vallone JG; Dunst CM; Johnson CS; Lada MJ; Louie BE; Watson TJ; DeMeester SR
J Gastrointest Surg; 2016 Jan; 20(1):140-4; discussion 144-5. PubMed ID: 26503261
[TBL] [Abstract][Full Text] [Related]
5. Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns.
Manner H; Wetzka J; May A; Pauthner M; Pech O; Fisseler-Eckhoff A; Stolte M; Vieth M; Lorenz D; Ell C
Dis Esophagus; 2017 Feb; 30(3):1-11. PubMed ID: 26952572
[TBL] [Abstract][Full Text] [Related]
6. Individual risk calculator to predict lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study.
Gotink AW; van de Ven SEM; Ten Kate FJC; Nieboer D; Suzuki L; Weusten BLAM; Brosens LAA; van Hillegersberg R; Alvarez Herrero L; Seldenrijk CA; Alkhalaf A; Moll FCP; Schoon EJ; van Lijnschoten I; Tang TJ; van der Valk H; Nagengast WB; Kats-Ugurlu G; Plukker JTM; Houben MHMG; van der Laan JS; Pouw RE; Bergman JJGHM; Meijer SL; van Berge Henegouwen MI; Wijnhoven BPL; de Jonge PJF; Doukas M; Bruno MJ; Biermann K; Koch AD
Endoscopy; 2022 Feb; 54(2):109-117. PubMed ID: 33626582
[TBL] [Abstract][Full Text] [Related]
7. Interobserver Variability in Assessment of Depth of Submucosal Invasion for Colonic Endoscopic Resections Among Subspecialized Gastrointestinal Pathologists.
Karamchandani DM; Westerhoff M; Arnold CA; Gonzalez RS; Westbrook LM; Goetz L; King TS; Panarelli NC
Arch Pathol Lab Med; 2022 May; 147(5):534-545. PubMed ID: 35943856
[TBL] [Abstract][Full Text] [Related]
8. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens.
Sepesi B; Watson TJ; Zhou D; Polomsky M; Litle VR; Jones CE; Raymond DP; Hu R; Qiu X; Peters JH
J Am Coll Surg; 2010 Apr; 210(4):418-27. PubMed ID: 20347733
[TBL] [Abstract][Full Text] [Related]
9. Prediction of lymph node status in superficial esophageal carcinoma.
Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
[TBL] [Abstract][Full Text] [Related]
10. The management and long-term outcomes of endoscopic and surgical treatment of early esophageal adenocarcinoma.
Saunders JH; Al-Zubaidi S; Waller RC; Ortiz-Fernandez-Sordo J; Parsons SL; Ragunath K; Kaye PV;
Dis Esophagus; 2020 Sep; 33(9):. PubMed ID: 32090253
[TBL] [Abstract][Full Text] [Related]
11. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma.
Ormsby AH; Petras RE; Henricks WH; Rice TW; Rybicki LA; Richter JE; Goldblum JR
Gut; 2002 Nov; 51(5):671-6. PubMed ID: 12377805
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma.
Maish MS; DeMeester SR
Ann Thorac Surg; 2004 Nov; 78(5):1777-82. PubMed ID: 15511474
[TBL] [Abstract][Full Text] [Related]
13. Lymphovascular invasion quantification could improve risk prediction of lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma.
van de Ven SEM; Suzuki L; Gotink AW; Ten Kate FJC; Nieboer D; Weusten BLAM; Brosens LAA; van Hillegersberg R; Alvarez Herrero L; Seldenrijk CA; Alkhalaf A; Moll FCP; Curvers W; van Lijnschoten IG; Tang TJ; van der Valk H; Nagengast WB; Kats-Ugurlu G; Plukker JTM; Houben MHMG; van der Laan JS; Pouw RE; Bergman JJGHM; Meijer SL; van Berge Henegouwen MI; Wijnhoven BPL; de Jonge PJF; Doukas M; Bruno MJ; Biermann K; Koch AD
United European Gastroenterol J; 2021 Nov; 9(9):1066-1073. PubMed ID: 34609076
[TBL] [Abstract][Full Text] [Related]
14. Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection.
Nakadoi K; Tanaka S; Kanao H; Terasaki M; Takata S; Oka S; Yoshida S; Arihiro K; Chayama K
J Gastroenterol Hepatol; 2012 Jun; 27(6):1057-62. PubMed ID: 22142484
[TBL] [Abstract][Full Text] [Related]
15. Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience.
Graham D; Sever N; Magee C; Waddingham W; Banks M; Sweis R; Al-Yousuf H; Mitchison M; Alzoubaidi D; Rodriguez-Justo M; Lovat L; Novelli M; Jansen M; Haidry R
World J Gastroenterol; 2018 Nov; 24(41):4698-4707. PubMed ID: 30416317
[TBL] [Abstract][Full Text] [Related]
16. Discordance Among Pathologists in the United States and Europe in Diagnosis of Low-Grade Dysplasia for Patients With Barrett's Esophagus.
Vennalaganti P; Kanakadandi V; Goldblum JR; Mathur SC; Patil DT; Offerhaus GJ; Meijer SL; Vieth M; Odze RD; Shreyas S; Parasa S; Gupta N; Repici A; Bansal A; Mohammad T; Sharma P
Gastroenterology; 2017 Feb; 152(3):564-570.e4. PubMed ID: 27818167
[TBL] [Abstract][Full Text] [Related]
17. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.
Schölvinck D; Künzli H; Meijer S; Seldenrijk K; van Berge Henegouwen M; Bergman J; Weusten B
Surg Endosc; 2016 Sep; 30(9):4102-13. PubMed ID: 27357927
[TBL] [Abstract][Full Text] [Related]
18. Risk of lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patients.
Gockel I; Sgourakis G; Lyros O; Polotzek U; Schimanski CC; Lang H; Hoppo T; Jobe BA
Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):371-84. PubMed ID: 21651355
[TBL] [Abstract][Full Text] [Related]
19. Treatment allocation in patients with early-stage esophageal adenocarcinoma: Prevalence and predictors of lymph node involvement.
Gamboa AM; Kim S; Force SD; Staley CA; Woods KE; Kooby DA; Maithel SK; Luke JA; Shaffer KM; Dacha S; Saba NF; Keilin SA; Cai Q; El-Rayes BF; Chen Z; Willingham FF
Cancer; 2016 Jul; 122(14):2150-7. PubMed ID: 27142247
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens.
Leers JM; DeMeester SR; Oezcelik A; Klipfel N; Ayazi S; Abate E; Zehetner J; Lipham JC; Chan L; Hagen JA; DeMeester TR
Ann Surg; 2011 Feb; 253(2):271-8. PubMed ID: 21119508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
